Lanean...
Machine learning designs non-hemolytic antimicrobial peptides
Machine learning (ML) consists of the recognition of patterns from training data and offers the opportunity to exploit large structure–activity databases for drug design. In the area of peptide drugs, ML is mostly being tested to design antimicrobial peptides (AMPs), a class of biomolecules potentia...
Gorde:
| Argitaratua izan da: | Chem Sci |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
The Royal Society of Chemistry
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8285431/ https://ncbi.nlm.nih.gov/pubmed/34349895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/d1sc01713f |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|